Lack Of Facts Dooms Class Cert Over Takeda Gout Drug
By Bryan Koenig · November 28, 2022, 9:16 PM EST
A federal judge last week rejected a bid by pharmacy chain Value Drug Co. to certify a class of roughly 50 purchasers of Takeda Pharmaceuticals' anti-gout drug Colcrys alleging that the...
To view the full article, register now.